enGene Therapeutics Inc. (ENGN)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 67
-0.04
-2.3392%
$
115.89M Market Cap
- P/E Ratio
- Div Yield
1.16M Volume
- Eps
$ 1.71
Previous Close Investors:
Want to track ENGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
enGene Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 13,992 | $24,206 | $23,926.32 | -$279.68 | -1.16% |
 Ilko Menkov Vestal Point Capita LLP | 1.67M | $2.88M | $2.78M | -$108,383.12 | -3.76% |
 Christopher C. Powers Farther Finance Advisors, LLC | 100 | $173 | $156 | -$17 | -9.83% |
 David Vollmer PFS Partners, LLC | 11,000 | $19,030 | $18,260 | -$770 | -4.05% |
 Raymond Debbane Siren, L.L.C. | 6.26M | $10.82M | $10.7M | -$125,133.24 | -1.16% |
| NCG Noah C Goldberg Jain Global LLC | 43,231 | $74,790 | $73,925.01 | -$864.99 | -1.16% |
| PLC Peapod Lane Capital LLC Peapod Lane Capital LLC | 1.1M | $1.91M | $1.84M | -$66,129.16 | -3.47% |
| AH Anders Hove Acorn Capital Advisors LLC | 1.27M | $2.2M | $2.11M | -$88,988.37 | -4.05% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 114,493 | $198,073 | $189,485.91 | -$8,587.09 | -4.34% |
2026 © Marketlog. All Rights Reserved.
